Rznomics Joins Lilly Gateway Labs in San Diego to Accelerate RNA Therapeutics
Rznomics joins Lilly Gateway Labs in San Diego to accelerate RNA therapeutics development, expand global partnerships and advance its pipeline of 200+ disease targets.
Lilly Catalyze360 | 25/08/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy